Kogan Bao serves as Executive at Oncobiologics, Inc., where they oversee executive responsibilities. Since joining the company, Kogan Bao has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 21, 2016 involved receiving (via award) 50,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 21, 2016 | ONS | $0 | Award | 50,000 | $N/A | Discretionary |
Kogan Bao currently holds 71,739 shares of Oncobiologics, Inc. (ONS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kogan Bao has been a net neutral trader of ONS stock. They have purchased $0 and sold $0 worth of shares.
Kogan Bao's most recent insider trade was on Dec 21, 2016, when they sold 50,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted